• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Riley Griffin

Stay informed with Riley Griffin’s coverage and analysis.

Johnson & Johnson shares jump as company follows GE and Toshiba in decision to split business apart
Finance
Johnson & Johnson shares jump as company follows GE and Toshiba in decision to split business apart
By Riley Griffin, John Lauerman and BloombergNovember 12, 2021
Moderna COVID-19 vials
Health
Moderna defends its COVID-19 vaccine, acknowledges heart risks in young men
By Riley Griffin and BloombergNovember 11, 2021
Merck’s breakthrough COVID pill faces a risk: the virus could outsmart it
Health
Merck’s breakthrough COVID pill faces a risk: the virus could outsmart it
By Thomas Mulier, Riley Griffin and BloombergOctober 8, 2021
Regeneron antibody COVID treatment
Health
Biden administration moves to prevent shortage of COVID-19 antibody treatments
By Riley Griffin, Emma Court and BloombergSeptember 15, 2021
Moderna seeks full FDA approval for its COVID-19 vaccine
Health
Moderna seeks full FDA approval for its COVID-19 vaccine
By Riley Griffin and BloombergAugust 25, 2021
Brainstorm Health 2020-Alex Gorsky
Health
Johnson & Johnson taps Duato as new CEO, replacing Gorsky
By Riley Griffin and BloombergAugust 20, 2021
Pfizer submits early data on the effects of third booster dose to FDA
Health
Pfizer submits early data on the effects of third booster dose to FDA
By Riley Griffin, Robert Langreth and BloombergAugust 16, 2021
Pfizer to deliver 200 million vaccines to the U.S. in push to protect kids
Health
Pfizer to deliver 200 million vaccines to the U.S. in push to protect kids
By Riley Griffin and BloombergJuly 23, 2021
J&J recalls some Neutrogena and Aveeno sunscreens after carcinogen found
Environment
J&J recalls some Neutrogena and Aveeno sunscreens after carcinogen found
By Anna Edney, Riley Griffin and BloombergJuly 14, 2021
Johnson & Johnson says its COVID vaccine helps protect against the delta variant
Health
Johnson & Johnson says its COVID vaccine helps protect against the delta variant
By Riley Griffin and BloombergJuly 2, 2021
U.S. to invest $3.2 billion into COVID antiviral program
Health
U.S. to invest $3.2 billion into COVID antiviral program
By Riley Griffin, Rebecca Torrence and BloombergJune 17, 2021
Healthcare Workers Administer Covid-19 Vaccines At Airport As U.S. Daily Cases Hit 14-Month Low
Health
Pfizer is launching a final study of the COVID-19 vaccine in children under 12
By Riley Griffin and BloombergJune 8, 2021
Merck takes huge hit for its abandoned COVID-19 drug efforts
Health
Merck takes huge hit for its abandoned COVID-19 drug efforts
By Riley Griffin and BloombergMay 6, 2021
GlaxoSmithKline gets rid of Trump’s vaccine adviser Slaoui for sexual harassment
Leadership
GlaxoSmithKline gets rid of Trump’s vaccine adviser Slaoui for sexual harassment
By James Paton, Riley Griffin and BloombergMarch 24, 2021
Teva Pharmaceutical Industries is in talks to manufacture and distribute COVID vaccines
Health
Teva Pharmaceutical Industries is in talks to manufacture and distribute COVID vaccines
By Riley Griffin and BloombergFebruary 10, 2021
1
  • 1
  • 2
  • 3
  • 4
4
Most Popular
AI
'Dr. Doom' Nouriel Roubini says we're headed for universal basic income or 'some form of socialism' as AI revolutionizes work—He calls that optimisticplaceholder alt text
By Jason MaJuly 18, 2026
Success
‘I want to die broke’: Billionaire philanthropist Denny Sanford dies after giving away $4 billionplaceholder alt text
By Sydney LakeJuly 20, 2026
AI
Power companies are using eminent domain to seize land for data centers as 70% of Americans say not in my backyardplaceholder alt text
By Aaron Walayat and The ConversationJuly 19, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.